{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T10:11:09Z","timestamp":1775211069688,"version":"3.50.1"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["HNO"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1007\/s00106-015-0008-7","type":"journal-article","created":{"date-parts":[[2015,4,30]],"date-time":"2015-04-30T17:22:00Z","timestamp":1430414520000},"page":"357-363","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["ASS-Intoleranz-Syndrom und persistierende Rhinosinusitis","ASA-intolerance syndrome and persistent rhinosinusitis"],"prefix":"10.1007","volume":"63","author":[{"given":"H.","family":"Kirsche","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Klimek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,5,1]]},"reference":[{"issue":"5","key":"8_CR1","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2500\/108854193778774065","volume":"14","author":"F Widal","year":"1993","unstructured":"Widal F, Abrami P, Lermoyez J (1993) Anaphylaxie et idiosyncrasie. Allergy Proc 14(5):373\u2013376 (discussion 371\u2013372)","journal-title":"Allergy Proc"},{"key":"8_CR2","first-page":"630","volume":"8","author":"O Pfaar","year":"2005","unstructured":"Pfaar O, Spielhaupter M, Klimek L (2005) Max Samter \u2013 ein Pionier und Wegbereiter der modernen Allergologie und Rhinologie. Allergo J 8:630\u2013634","journal-title":"Allergo J"},{"key":"8_CR3","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0272-5231(21)00582-7","volume":"9(4","author":"HJ Zeitz","year":"1988","unstructured":"Zeitz HJ (1988) Bronchial asthma, nasal polyps, and aspirin sensitivity: Samter\u2019s syndrome. Clin Chest Med 9(4:567\u2013576","journal-title":"Clin Chest Med"},{"key":"8_CR4","first-page":"233","volume-title":"Praktische Allergologie \u2013 Schwerpunkt HNO-Heilkunde","author":"A Schapowal","year":"1998","unstructured":"Schapowal A (1998) Pseudoallergische Reaktionen auf nicht steroidale Antiphlogistika. In: Heppt W, Bachert C (Hrsg) Praktische Allergologie \u2013 Schwerpunkt HNO-Heilkunde. Thieme, Stuttgart, S 233\u2013238"},{"issue":"4","key":"8_CR5","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1445-5994.2004.00801.x","volume":"35","author":"K Morwood","year":"2005","unstructured":"Morwood K, Gillis D, Smith W, Kette F (2005) Aspirin-sensitive asthma. Intern Med J 35(4):240\u2013246","journal-title":"Intern Med J"},{"issue":"3","key":"8_CR6","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1034\/j.1399-3003.2000.016003432.x","volume":"16","author":"A Szczeklik","year":"2000","unstructured":"Szczeklik A, Nizankowska E, Duplaga M (2000) Natural history of aspirin-induced asthma. AIANE Investigators. European Network on Aspirin-Induced Asthma. Eur Respir J 16(3):432\u2013436","journal-title":"Eur Respir J"},{"issue":"1","key":"8_CR7","first-page":"53","volume":"79","author":"W Hosemann","year":"2000","unstructured":"Hosemann W, Kuhnel T, Pfeifer M (2000) Analgesic intolerance and nasal polyps. Laryngorhinootologie 79(1):53\u201365","journal-title":"Laryngorhinootologie"},{"issue":"4","key":"8_CR8","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/ije\/28.4.717","volume":"28","author":"J Hedman","year":"1999","unstructured":"Hedman J, Kaprio J, Poussa T, Nieminen MM (1999) Prevalence of asthma, aspirin intolerance, nasal polyposis and chronic obstructive pulmonary disease in a population-based study. Int J Epidemiol 28(4):717\u2013722","journal-title":"Int J Epidemiol"},{"issue":"1","key":"8_CR9","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1067\/mai.2003.7","volume":"111","author":"MP Berges-Gimeno","year":"2003","unstructured":"Berges-Gimeno MP, Simon RA, Stevenson DD (2003) Long-term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol 111(1):180\u2013186","journal-title":"J Allergy Clin Immunol"},{"issue":"20","key":"8_CR10","first-page":"1","volume":"2007","author":"W Fokkens","year":"2007","unstructured":"Fokkens W, Lund V, Mullol J (2007) European position paper on rhinosinusitis and nasal polyps 2007. Rhinol Suppl 2007(20):1\u2013136","journal-title":"Rhinol Suppl"},{"issue":"7","key":"8_CR11","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1080\/00016480701724896","volume":"128","author":"J Gosepath","year":"2008","unstructured":"Gosepath J, Pogodsky T, Mann WJ (2008) Characteristics of recurrent chronic rhinosinusitis after previous surgical therapy. Acta Otolaryngol 128(7):778\u2013784","journal-title":"Acta Otolaryngol"},{"issue":"5","key":"8_CR12","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S1081-1206(10)62084-4","volume":"89","author":"MP Berges-Gimeno","year":"2002","unstructured":"Berges-Gimeno MP, Simon RA, Stevenson DD (2002) The natural history and clinical characteristics of aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol 89(5):474\u2013478","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"12","key":"8_CR13","first-page":"631","volume":"29","author":"I Caplin","year":"1971","unstructured":"Caplin I, Haynes JT, Spahn J (1971) Are nasal polyps an allergic phenomenon? Ann Allergy 29(12):631\u2013634","journal-title":"Ann Allergy"},{"issue":"5","key":"8_CR14","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2500\/108854196778662255","volume":"17","author":"K Larsen","year":"1996","unstructured":"Larsen K (1996) The clinical relationship of nasal polyps to asthma. Allergy Asthma Proc 17(5):243\u2013249","journal-title":"Allergy Asthma Proc"},{"issue":"6","key":"8_CR15","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/S1081-1206(10)61323-3","volume":"94","author":"K Mascia","year":"2005","unstructured":"Mascia K, Borish L, Patrie J, Hunt J, Phillips CD, Steinke JW (2005) Chronic hyperplastic eosinophilic sinusitis as a predictor of aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol 94(6):652\u2013657","journal-title":"Ann Allergy Asthma Immunol"},{"key":"8_CR16","first-page":"21","volume":"430","author":"S Ogino","year":"1986","unstructured":"Ogino S, Harada T, Okawachi I, Irifune M, Matsunaga T, Nagano T (1986) Aspirin-induced asthma and nasal polyps. Acta Otolaryngol Suppl 430:21\u201327","journal-title":"Acta Otolaryngol Suppl"},{"key":"8_CR17","volume-title":"Nasal polyps: epidemiology, pathogenesis and treatment","author":"GA Settipane","year":"1997","unstructured":"Settipane GA (1997) Nasal polyps: epidemiology, pathogenesis and treatment. Oceanside Publications, Rhode Island"},{"issue":"4","key":"8_CR18","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/0091-6749(74)90081-5","volume":"53","author":"GA Settipane","year":"1974","unstructured":"Settipane GA, Chafee FH, Klein DE (1974) Aspirin intolerance. II. A prospective study in an atopic and normal population. J Allergy Clin Immunol 53(4):200\u2013204","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"8_CR19","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s11882-009-0023-4","volume":"9","author":"DD Stevenson","year":"2009","unstructured":"Stevenson DD (2009) Aspirin sensitivity and desensitization for asthma and sinusitis. Curr Allergy Asthma Rep 9(2):155\u2013163","journal-title":"Curr Allergy Asthma Rep"},{"issue":"5","key":"8_CR20","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1067\/mai.2003.1487","volume":"111","author":"A Szczeklik","year":"2003","unstructured":"Szczeklik A, Stevenson DD (2003) Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management. J Allergy Clin Immunol 111(5):913\u2013921 (quiz 922)","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"8_CR21","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S0091-6749(96)70102-1","volume":"98","author":"J Quiralte","year":"1996","unstructured":"Quiralte J, Blanco C, Castillo R, Delgado J, Carrillo T (1996) Intolerance to nonsteroidal antiinflammatory drugs: results of controlled drug challenges in 98 patients. J Allergy Clin Immunol 98(3):678\u2013685","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"8_CR22","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1017\/S0022215100147061","volume":"98","author":"G Hillerdal","year":"1984","unstructured":"Hillerdal G, Lindholm H (1984) Laryngeal edema as the only symptom of hypersensitivity to salicylic acid and other substances. J Laryngol Otol 98(5):547\u2013548","journal-title":"J Laryngol Otol"},{"key":"8_CR23","first-page":"251","volume":"5","author":"HW Baenkler","year":"2006","unstructured":"Baenkler HW (2006) Intoleranz gegen\u00fcber Salicylaten\/Analgetika. Bayr Internist 5:251\u2013260","journal-title":"Bayr Internist"},{"issue":"1","key":"8_CR24","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1610-0387.2007.06194.x","volume":"5","author":"YA Buss","year":"2007","unstructured":"Buss YA, Garrelfs UC, Sticherling M (2007) Chronic urticaria \u2013 which clinical parameters are pathogenetically relevant? A retrospective investigation of 339 patients. J Dtsch Dermatol Ges 5(1):22\u201329","journal-title":"J Dtsch Dermatol Ges"},{"issue":"9","key":"8_CR25","doi-asserted-by":"crossref","first-page":"599","DOI":"10.2165\/00128071-200203090-00002","volume":"3","author":"M Sanchez-Borges","year":"2002","unstructured":"Sanchez-Borges M, Capriles-Hulett A, Caballero-Fonseca F (2002) NSAID-induced urticaria and angioedema: a reappraisal of its clinical management. Am J Clin Dermatol 3(9):599\u2013607","journal-title":"Am J Clin Dermatol"},{"issue":"5","key":"8_CR26","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1378\/chest.118.5.1470","volume":"118","author":"KS Babu","year":"2000","unstructured":"Babu KS, Salvi SS (2000) Aspirin and asthma. Chest 118(5):1470\u20131476","journal-title":"Chest"},{"issue":"7","key":"8_CR27","doi-asserted-by":"crossref","first-page":"240","DOI":"10.5414\/ALP30240","volume":"30","author":"R Dollner","year":"2007","unstructured":"Dollner R, Klimek L, Pfaar O, Stuck BA, H\u00f6rmann K (2007) In-vitro-Testverfahren bei Analgetikaintoleranz. Allergologie 30(7):240\u2013248","journal-title":"Allergologie"},{"issue":"8","key":"8_CR28","first-page":"137","volume":"105","author":"HW Baenkler","year":"2008","unstructured":"Baenkler HW (2008) Salicylate intolerance: pathophysiology, clinical spectrum, diagnosis and treatment. Dtsch Arztebl Int 105(8):137\u2013142","journal-title":"Dtsch Arztebl Int"},{"issue":"12","key":"8_CR29","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s00106-012-2588-9","volume":"60","author":"L Klimek","year":"2012","unstructured":"Klimek L, Goebel U, Glowania A (2012) Management of anaphylaxis: part 2: treatment and emergency equipment. HNO 60(12):1103\u20131113","journal-title":"HNO"},{"issue":"1","key":"8_CR30","first-page":"79","volume":"58","author":"S Albu","year":"2004","unstructured":"Albu S, Tomescu E, Mexca Z, Nistor S, Necula S, Cozlean A (2004) Recurrence rates in endonasal surgery for polyposis. Acta Otorhinolaryngol Belg 58(1):79\u201386","journal-title":"Acta Otorhinolaryngol Belg"},{"issue":"10","key":"8_CR31","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1007\/s00106-007-1589-6","volume":"55","author":"BA Stuck","year":"2007","unstructured":"Stuck BA, Bachert C, Federspil P, Hosemann W, Klimek L, Mosges R et al (2007) Rhinosinusitis guidelines of the German Society for Otorhinolaryngology, Head and Neck Surgery. HNO 55(10):758\u2013777","journal-title":"HNO"},{"issue":"3","key":"8_CR32","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000086075","volume":"67","author":"J Gosepath","year":"2005","unstructured":"Gosepath J, Mann WJ (2005) Current concepts in therapy of chronic rhinosinusitis and nasal polyposis. ORL J Otorhinolaryngol Relat Spec 67(3):125\u2013136","journal-title":"ORL J Otorhinolaryngol Relat Spec"},{"issue":"3","key":"8_CR33","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1177\/000348941112000304","volume":"120","author":"D Mendelsohn","year":"2011","unstructured":"Mendelsohn D, Jeremic G, Wright ED, Rotenberg BW (2011) Revision rates after endoscopic sinus surgery: a recurrence analysis. Ann Otol Rhinol Laryngol 120(3):162\u2013166","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"6","key":"8_CR34","doi-asserted-by":"crossref","first-page":"573","DOI":"10.2500\/ajr.2006.20.2913","volume":"20","author":"KC McMains","year":"2006","unstructured":"McMains KC, Kountakis SE (2006) Medical and surgical considerations in patients with Samter\u2019s triad. Am J Rhinol 20(6):573\u2013576","journal-title":"Am J Rhinol"},{"issue":"3","key":"8_CR35","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.4049\/jimmunol.163.3.1545","volume":"163","author":"FL Jahnsen","year":"1999","unstructured":"Jahnsen FL, Haye R, Gran E, Brandtzaeg P, Johansen FE (1999) Glucocorticosteroids inhibit mRNA expression for eotaxin, eotaxin\u20112, and monocyte-chemotactic protein\u20114 in human airway inflammation with eosinophilia. J Immunol 163(3):1545\u20131551","journal-title":"J Immunol"},{"issue":"1","key":"8_CR36","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jaci.2006.03.012","volume":"118","author":"P Hissaria","year":"2006","unstructured":"Hissaria P, Smith W, Wormald PJ, Taylor J, Vadas M, Gillis D et al (2006) Short course of systemic corticosteroids in sinonasal polyposis: a double-blind, randomized, placebo-controlled trial with evaluation of outcome measures. J Allergy Clin Immunol 118(1):128\u2013133","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"8_CR37","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1097\/01.mlg.0000205218.37514.0f","volume":"116","author":"P Benitez","year":"2006","unstructured":"Benitez P, Alobid I, de Haro J, Berenguer J, Bernal-Sprekelsen M, Pujols L et al (2006) A short course of oral prednisone followed by intranasal budesonide is an effective treatment of severe nasal polyps. Laryngoscope 116(5):770\u2013775","journal-title":"Laryngoscope"},{"issue":"3","key":"8_CR38","first-page":"144","volume":"20","author":"G Karlsson","year":"1982","unstructured":"Karlsson G, Rundcrantz H (1982) A randomized trial of intranasal beclomethasone dipropionate after polypectomy. Rhinology 20(3):144\u2013148","journal-title":"Rhinology"},{"issue":"1","key":"8_CR39","first-page":"9","volume":"18","author":"E Virolainen","year":"1980","unstructured":"Virolainen E, Puhakka H (1980) The effect of intranasal beclomethasone dipropionate on the recurrence of nasal polyps after ethmoidectomy. Rhinology 18(1):9\u201318","journal-title":"Rhinology"},{"issue":"1","key":"8_CR40","first-page":"49","volume":"23","author":"G Dingsor","year":"1985","unstructured":"Dingsor G, Kramer J, Olsholt R, Soderstrom T (1985) Flunisolide nasal spray 0.025\u2009% in the prophylactic treatment of nasal polyposis after polypectomy. A randomized, double blind, parallel, placebo controlled study. Rhinology 23(1):49\u201358","journal-title":"Rhinology"},{"issue":"3","key":"8_CR41","first-page":"149","volume":"20","author":"B Drettner","year":"1982","unstructured":"Drettner B, Ebbesen A, Nilsson M (1982) Prophylactive treatment with flunisolide after polypectomy. Rhinology 20(3):149\u2013158","journal-title":"Rhinology"},{"issue":"2","key":"8_CR42","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1017\/S0022215100104372","volume":"102","author":"S Hartwig","year":"1988","unstructured":"Hartwig S, Linden M, Laurent C, Vargo AK, Lindqvist N (1988) Budesonide nasal spray as prophylactic treatment after polypectomy (a double blind clinical trial). J Laryngol Otol 102(2):148\u2013151","journal-title":"J Laryngol Otol"},{"issue":"3","key":"8_CR43","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1001\/archoto.2009.2","volume":"135","author":"P Stjarne","year":"2009","unstructured":"Stjarne P, Olsson P, Alenius M (2009) Use of mometasone furoate to prevent polyp relapse after endoscopic sinus surgery. Arch Otolaryngol Head Neck Surg 135(3):296\u2013302","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"1","key":"8_CR44","first-page":"1","volume":"22","author":"J Sastre","year":"2012","unstructured":"Sastre J, Mosges R (2012) Local and systemic safety of intranasal corticosteroids. J Investig Allergol Clin Immunol 22(1):1\u201312","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"7","key":"8_CR45","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s00106-012-2483-4","volume":"60","author":"L Klimek","year":"2012","unstructured":"Klimek L, Hogger P, Pfaar O (2012) Mechanism of action of nasal glucocorticosteroids in the treatment of allergic rhinitis. Part 1: Pathophysiology, molecular basis. HNO 60(7):611\u2013617","journal-title":"HNO"},{"issue":"Suppl 57","key":"8_CR46","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1398-9995.1999.tb04413.x","volume":"54","author":"C Bachert","year":"1999","unstructured":"Bachert C, Geveart P (1999) Effect of intranasal corticosteroids on release of cytokines and inflammatory mediators. Allergy 54(Suppl 57):116\u2013123","journal-title":"Allergy"},{"issue":"11","key":"8_CR47","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1177\/000348941212101104","volume":"121","author":"AH Shikani","year":"2012","unstructured":"Shikani AH, Kourelis K, Rohayem Z, Basaraba RJ, Leid JG (2012) Topical gel therapy for sinonasal polyposis in Samter\u2019s triad: preliminary report. Ann Otol Rhinol Laryngol 121(11):719\u2013724","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"1","key":"8_CR48","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1164\/ajrccm.165.1.2010080","volume":"165","author":"SE Dahlen","year":"2002","unstructured":"Dahlen SE, Malmstrom K, Nizankowska E, Dahlen B, Kuna P, Kowalski M et al (2002) Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial. Am J Respir Crit Care Med 165(1):9\u201314","journal-title":"Am J Respir Crit Care Med"},{"issue":"9146","key":"8_CR49","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0140-6736(98)09019-9","volume":"353","author":"BJ Lipworth","year":"1999","unstructured":"Lipworth BJ (1999) Leukotriene-receptor antagonists. Lancet 353(9146):57\u201362","journal-title":"Lancet"},{"issue":"4","key":"8_CR50","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1055\/s-2007-966094","volume":"86","author":"C Pauli","year":"2007","unstructured":"Pauli C, Fintelmann R, Klemens C, Hilgert E, Jund F, Rasp G et al (2007) Polyposis nasi \u2013 improvement in quality of life by the influence of leukotrien receptor antagonists. Laryngorhinootologie 86(4):282\u2013286","journal-title":"Laryngorhinootologie"},{"issue":"4","key":"8_CR51","doi-asserted-by":"crossref","first-page":"210","DOI":"10.5606\/kbbihtisas.2011.028","volume":"21","author":"ZM Yazici","year":"2011","unstructured":"Yazici ZM, Sayin I, Bozkurt E, Kayhan FT (2011) Effect of montelukast on quality of life in subjects with nasal polyposis accompanying bronchial asthma. Kulak Burun Bogaz Ihtis Derg 21(4):210\u2013214","journal-title":"Kulak Burun Bogaz Ihtis Derg"},{"issue":"4","key":"8_CR52","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0091-6749(96)70123-9","volume":"98","author":"DD Stevenson","year":"1996","unstructured":"Stevenson DD, Hankammer MA, Mathison DA, Christiansen SC, Simon RA (1996) Aspirin desensitization treatment of aspirin-sensitive patients with rhinosinusitis-asthma: long-term outcomes. J Allergy Clin Immunol 98(4):751\u2013758","journal-title":"J Allergy Clin Immunol"},{"issue":"1 Pt 1","key":"8_CR53","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0091-6749(90)90222-P","volume":"85","author":"JM Sweet","year":"1990","unstructured":"Sweet JM, Stevenson DD, Simon RA, Mathison DA (1990) Long-term effects of aspirin desensitization \u2013 treatment for aspirin-sensitive rhinosinusitis-asthma. J Allergy Clin Immunol 85(1 Pt 1):59\u201365","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"8_CR54","first-page":"17","volume":"36","author":"M Schmitz-Schumann","year":"1982","unstructured":"Schmitz-Schumann M, Schaub E, Virchow C (1982) Inhalation provocation test with lysine-acetylsalicylic acid in patients with analgetics-induced asthma (author\u2019s transl). Prax Klin Pneumol 36(1):17\u201321","journal-title":"Prax Klin Pneumol"},{"issue":"1","key":"8_CR55","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/0091-6749(80)90143-8","volume":"66","author":"DD Stevenson","year":"1980","unstructured":"Stevenson DD, Simon RA, Mathison DA (1980) Aspirin-sensitive asthma: tolerance to aspirin after positive oral aspirin challenges. J Allergy Clin Immunol 66(1):82\u201388","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"8_CR56","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4193\/Rhino09.113","volume":"49","author":"B Forer","year":"2011","unstructured":"Forer B, Kivity S, Sade J, Landsberg R (2011) Aspirin desensitization for ASA triad patients \u2013 prospective study of the rhinologist\u2019s perspective. Rhinology 49(1):95\u201399","journal-title":"Rhinology"},{"issue":"1","key":"8_CR57","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00063198-200401000-00009","volume":"10","author":"A Szczeklik","year":"2004","unstructured":"Szczeklik A, Sanak M, Nizankowska-Mogilnicka E, Kielbasa B (2004) Aspirin intolerance and the cyclooxygenase-leukotriene pathways. Curr Opin Pulm Med 10(1):51\u201356","journal-title":"Curr Opin Pulm Med"},{"issue":"5","key":"8_CR58","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/0091-6749(76)90059-2","volume":"57","author":"CR Zeiss","year":"1976","unstructured":"Zeiss CR, Lockey RF (1976) Refractory period to aspirin in a patient with aspirin-induced asthma. J Allergy Clin Immunol 57(5):440\u2013448","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"8_CR59","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1097\/01.MLG.0000166702.38850.1B","volume":"115","author":"AA Parikh","year":"2005","unstructured":"Parikh AA, Scadding GK (2005) Intranasal lysine-aspirin in aspirin-sensitive nasal polyposis: a controlled trial. Laryngoscope 115(8):1385\u20131390","journal-title":"Laryngoscope"},{"issue":"5","key":"8_CR60","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S1081-1206(10)61101-5","volume":"97","author":"A White","year":"2006","unstructured":"White A, Ludington E, Mehra P, Stevenson DD, Simon RA (2006) Effect of leukotriene modifier drugs on the safety of oral aspirin challenges. Ann Allergy Asthma Immunol 97(5):688\u2013693","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"10","key":"8_CR61","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1055\/s-2002-35002","volume":"81","author":"J Gosepath","year":"2002","unstructured":"Gosepath J, Schafer D, Mann WJ (2002) Aspirin sensitivity: long term follow-up after up to 3 years of adaptive desensitization using a maintenance dose of 100\u00a0mg of aspirin a day. Laryngorhinootologie 81(10):732\u2013738","journal-title":"Laryngorhinootologie"},{"issue":"1","key":"8_CR62","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/clc.22054","volume":"36","author":"KL McMullan","year":"2013","unstructured":"McMullan KL, Wedner HJ (2013) Safety of aspirin desensitization in patients with reported aspirin allergy and cardiovascular disease. Clin Cardiol 36(1):25\u201330","journal-title":"Clin Cardiol"},{"issue":"8","key":"8_CR63","doi-asserted-by":"crossref","first-page":"322","DOI":"10.5414\/ALP29322","volume":"29","author":"O Pfaar","year":"2006","unstructured":"Pfaar O, Spielhaupter M, Wrede H (2006) Aspirin desensitization on patients with aspirin intolerance and nasal polyps \u2013 a new therapeutic approach by the intravenous route. Allergologie 29(8):322\u2013331","journal-title":"Allergologie"},{"issue":"4","key":"8_CR64","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.iac.2009.07.008","volume":"29","author":"L Klimek","year":"2009","unstructured":"Klimek L, Pfaar O (2009) Aspirin intolerance: does desensitization alter the course of the disease? Immunol Allergy Clin North Am 29(4):669\u2013675","journal-title":"Immunol Allergy Clin North Am"},{"issue":"3","key":"8_CR65","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.all.0000225153.45027.6a","volume":"6","author":"O Pfaar","year":"2006","unstructured":"Pfaar O, Klimek L (2006) Aspirin desensitization in aspirin intolerance: update on current standards and recent improvements. Curr Opin Allergy Clin Immunol 6(3):161\u2013166","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"9","key":"8_CR66","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1007\/s00108-010-2661-y","volume":"51","author":"C Umbreit","year":"2010","unstructured":"Umbreit C, Virchow JC, Thorn C, Hormann K, Klimek L, Pfaar O (2010) Aspirin-Intolerance-Syndrom : a common and interdisciplinary disease. Internist (Berl) 51(9):1196\u20131198 (1200\u20131191)","journal-title":"Internist (Berl)"},{"issue":"1","key":"8_CR67","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jaci.2006.09.011","volume":"119","author":"JY Lee","year":"2007","unstructured":"Lee JY, Simon RA, Stevenson DD (2007) Selection of aspirin dosages for aspirin desensitization treatment in patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol 119(1):157\u2013164","journal-title":"J Allergy Clin Immunol"},{"issue":"9","key":"8_CR68","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1111\/j.1398-9995.2008.01658.x","volume":"63","author":"A Rozsasi","year":"2008","unstructured":"Rozsasi A, Polzehl D, Deutschle T, Smith E, Wiesmiller K, Riechelmann H et al (2008) Long-term treatment with aspirin desensitization: a prospective clinical trial comparing 100 and 300\u00a0mg aspirin daily. Allergy 63(9):1228\u20131234","journal-title":"Allergy"},{"issue":"2","key":"8_CR69","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00405-012-2048-x","volume":"270","author":"M Havel","year":"2013","unstructured":"Havel M, Ertl L, Braunschweig F, Markmann S, Leunig A, Gamarra F et al (2013) Sinonasal outcome under aspirin desensitization following functional endoscopic sinus surgery in patients with aspirin triad. Eur Arch Otorhinolaryngol 270(2):571\u2013578","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"11","key":"8_CR70","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1111\/all.12269","volume":"68","author":"S Comert","year":"2013","unstructured":"Comert S, Celebioglu E, Yucel T, Erdogan T, Karakaya G, Onerci M et al (2013) Aspirin 300\u00a0mg\/day is effective for treating aspirin-exacerbated respiratory disease. Allergy 68(11):1443\u20131451","journal-title":"Allergy"},{"issue":"5","key":"8_CR71","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/all.12131","volume":"68","author":"K Fruth","year":"2013","unstructured":"Fruth K, Pogorzelski B, Schmidtmann I, Springer J, Fennan N, Fraessdorf N et al (2013) Low-dose aspirin desensitization in individuals with aspirin-exacerbated respiratory disease. Allergy 68(5):659\u2013665","journal-title":"Allergy"},{"issue":"4","key":"8_CR72","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00106-011-2444-3","volume":"60","author":"R Weber","year":"2012","unstructured":"Weber R, Trautmann A, Randerath W, Heppt W, Hosemann W (2012) Aspirin desensitization: therapy options in patients with aspirin-exacerbated respiratory disease. HNO 60(4):369\u2013383","journal-title":"HNO"},{"issue":"3","key":"8_CR73","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/MOO.0b013e3283450102","volume":"19","author":"H Rizk","year":"2011","unstructured":"Rizk H (2011) Role of aspirin desensitization in the management of chronic rhinosinusitis. Curr Opin Otolaryngol Head Neck Surg 19(3):210\u2013217","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"issue":"5","key":"8_CR74","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.ejvs.2009.01.009","volume":"37","author":"E Tournoij","year":"2009","unstructured":"Tournoij E, Peters RJ, Langenberg M, Kanhai KJ, Moll FL (2009) The prevalence of intolerance for low-dose acetylsalicylacid in the secondary prevention of atherothrombosis. Eur J Vasc Endovasc Surg 37(5):597\u2013603","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"1","key":"8_CR75","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jaci.2014.07.031","volume":"135","author":"KN Cahill","year":"2015","unstructured":"Cahill KN, Bensko JC, Boyce JA, Laidlaw TM (2015) Prostaglandin D2: A dominant mediator of aspirin-exacerbated respiratory disease. J Allergy Clin Immunol 135(1):245\u2013252","journal-title":"J Allergy Clin Immunol"}],"container-title":["HNO"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00106-015-0008-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00106-015-0008-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00106-015-0008-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T23:37:31Z","timestamp":1691624251000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00106-015-0008-7"}},"subtitle":["Differentialdiagnostik und Therapie","Differential diagnosis and treatment"],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":75,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["8"],"URL":"https:\/\/doi.org\/10.1007\/s00106-015-0008-7","relation":{},"ISSN":["0017-6192","1433-0458"],"issn-type":[{"value":"0017-6192","type":"print"},{"value":"1433-0458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5]]}}}